COMPARATIVE ANALYSIS OF THE CONTENT IN LYMPH OF HORMONES DRAWING IN PATHOGENESIS OF BREAST CANCER IN RATS WISTAR
Abstract
About the Authors
A. P. LykovRussian Federation
M. A. Bondarenko
Russian Federation
O. V. Poveshchenko
Russian Federation
A. V. Kabakov
Russian Federation
T. V. Rayter
Russian Federation
O. V. Kazakov
Russian Federation
D. N. Strunkin
Russian Federation
A. F. Poveshchenko
Russian Federation
V. I. Konenkov
Russian Federation
References
1. Besednova N.N., Fedyanina L.N. Anticancer effect of exogenous deoxyribonucleic acid // Tihookeanskij medicinskij zhurnal. 2009. № 3. P. 12–18. [in Russian]
2. Stenina M.B., Frolova M.A. Breast cancer: the most important scientific events and the conclusions of the last years // Prakticheskaja onkologija. 2011. № 1. P. 6–11. [in Russian]
3. Bernichtein S., Touraine P., Goffin V. New concepts in prolactin biology // J. Endocrinology. 2010. Vol. 206 (1). P. 1–11. doi: 10.1677/JOE-10-0069.
4. Clemons M., Goss P. Estrogen and the risk of breast cancer // N. Engl. J. Med. 2001. Vol. 344 (4). P. 276–285.
5. Farhat G.N., Cummings S.R., Chlebowski R.T., Parimi N., Cauley J.A., Rohan T.E., Huang A.J., Vitolins M., Hubbell F.A., Manson J.E., Cochrane B.B., Lane D.S., Lee J.S. Sex hormone levels and risks of estrogen receptor–negative and estrogen receptor–positive breast cancers // J. Natl. Cancer Inst. 2011. Vol. 103 (7). P. 562–570. doi: 10.1093/jnci/djr031.
6. Figueiredo H.F., Ulrich-Lai Y.M., Choi D.C., Herman J.P. Estrogen potentiates adrenocortical responses to stress in female rats // Am. J. Physiol. Endocrinol. Metab. 2007. Vol. 292 (4). P. 1173–1182.
7. Nitze L.M., Galsgaard E.D., Din N., Lund V.L., Rasmussen B.B., Berchtold M.W., Christensen L., Panina S. Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer // Breast Cancer Res. Treat. 2013. Vol. 142 (1). P. 31–44. doi: 10.1007/s10549013-2731-7.
8. Rose D.P., Davis T.E. Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients // Cancer Res. 1980. Vol. 40 (11). P. 4043–4047.
9. Suba Z. Circulatory estrogen level protects against breast cancer in obese women // Recent. Pat. AntiCancer Drug Discov. 2013. Vol. 8 (2). P. 154–167.
10. Szychta P., Szychta W., Gesing A., Lewiński A., KarbownikLewińska M. TSH receptor antibodies have predictive value for breast cancer – retrospective analysis // Thyroid Research. 2013. Vol. 6 (1). P. 8–15. doi: 10.1186/1756-6614-6-8.
11. Zhou J., Chen Y., Huang Y., Long J., Wan F., Zhang S. Serum follicle-stimulating hormone level is associated with human epidermal growth factor receptor type 2 and Ki67 expression in post-menopausal females with breast cancer // Oncology letters. 2013. Vol. 6 (4). P. 1128–1132.
Review
For citations:
Lykov A.P., Bondarenko M.A., Poveshchenko O.V., Kabakov A.V., Rayter T.V., Kazakov O.V., Strunkin D.N., Poveshchenko A.F., Konenkov V.I. COMPARATIVE ANALYSIS OF THE CONTENT IN LYMPH OF HORMONES DRAWING IN PATHOGENESIS OF BREAST CANCER IN RATS WISTAR. Siberian journal of oncology. 2015;1(1):64-67. (In Russ.)